
Milestone Scientific (MLSS) Stock Forecast & Price Target
Milestone Scientific (MLSS) Analyst Ratings
Bulls say
Milestone Scientific Inc. is projected to experience a sales growth rate of 20% as the medical segment begins to contribute modestly in 2025 and accelerates further in 2026. This expected increase in revenue is supported by enhanced coverage of the CompuFlo procedure by more Medicare Administrative Contractors (MACs) and a strategic shift towards direct online sales in the dental sector. Additionally, the company has demonstrated significant improvement in profitability, with gross margins rising to 76.1% in the second quarter of 2024, up from 65% in the same quarter the previous year.
Bears say
Milestone Scientific Inc. faces potential financial challenges due to the need for increased investment in inventory and marketing, which may strain working capital and delay profitability. Additionally, a significant percentage of second dental appointments are canceled due to patient apprehension, contributing to lost revenue for dentists and impacting the company's sales. Lastly, adverse economic conditions or shifts in healthcare reimbursement may result in dentists being hesitant to invest in the company’s technology, further suppressing growth prospects.
This aggregate rating is based on analysts' research of Milestone Scientific and is not a guaranteed prediction by Public.com or investment advice.
Milestone Scientific (MLSS) Analyst Forecast & Price Prediction
Start investing in Milestone Scientific (MLSS)
Order type
Buy in
Order amount
Est. shares
0 shares